← Back to all trials
Not Yet Recruiting
NCT07655804
Subcutaneous Calcitonin in Acute Herpes Zoster
Conditions: Calcitonin, Subcutaneous, Acute Herpes Zoster
Sex: All
Ages: 50 Years – N/A
Healthy volunteers: No
Phase: PHASE3
Enrollment: 168
Sponsor: Tanta University
Location: Tanta University Hospitals Tanta Gharbia Governorate
Summary
This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.
Eligibility Criteria
Inclusion Criteria:
* patients aged ≥ 50 years, with acute herpes zoster infection (rash duration \< 7 days) and moderate to severe pain.
Exclusion Criteria:
* Coagulation abnormalities
* Pre-existing other pain syndrome or psychological disorders.
* Severe hepatic, cardiovascular, or renal disorders.
* Allergy to calcitonin.
Source: ClinicalTrials.gov (NCT07655804). StuddyBuddy aggregates publicly available trial information.
